Regeneron is a leading science and technology company dedicated to inventing, developing and commercializing life-transforming treatments for serious diseases. Our mission is to use the power of science to bring new medicines to patients… over and over again.
Founded and led by physician-scientists since 1988, Regeneron has more than 12,000 employees around the world, with locations in North America, Europe and Asia. Regeneron-invented medicines are available in over 100 countries and are being studied in clinical trials in approximately 60 countries.
Our unique ability to repeatedly and consistently translate science into medicine has led to numerous medicines authorized by regulatory agencies around the world and dozens of investigational product candidates in development, almost all of which were homegrown in our laboratories.
In addition to our medicines, our innovations include the VelociSuite® drug discovery and development technologies, world-class manufacturing operations, one of the largest human genetics sequencing efforts in the world and rapid response technologies being used for global good.
